Longitudinal HLA-Class I and II-driven evolution of Hepititis C virus (HCV) in acurately infected patients with different infection outcomes-implication for current therapy and vaccine design

Prize: Prize/awardIn-kind Award

Description

Amount Awarded: $25,000
Project Role: Chief Investigator- A
Granting OrganisationsRoche Products Pty Ltd

    Fingerprint